Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fibrinogen antagonists reported by Searle

Oct. 4, 1996

Boehringer Mannheim reports fibrinogen antagonists for thromboembolic conditions

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Interim phase II results reported for Neutralase

Oct. 4, 1996

Gensia and Microbix agreement for generic urokinase alternative

Sep. 27, 1996

Tanabe reports t-PA-enhancing compounds

Sep. 27, 1996

gpIIb/IIIa antagonist selected for clinical evaluation at DuPont Merck

Sep. 27, 1996

DuPont Merck proposes new standards for warfarin products

Sep. 27, 1996

Thrombin inhibitors with improved selectivity from Servier

Sep. 27, 1996

Antiplatelet ketoprofen analogue from Fuji Chem.

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...